Epidemiology of systemic sclerosis and related diseases

Current Opinion in Rheumatology

Volumn 9, Issue 6, 1997, Pages 557-561

  Mayes, Maureen D ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; SYSTEMIC SCLEROSIS;

EID: 0030777686     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199711000-00012     Document Type: Review

References (33)

1. Medsger TA, Jr, Masi AT Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971, 74:714-719.
2. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT: Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985, 60:105-113.
3. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr: Incidence of systemic sclerosis in Allegheny County, Pennsylvania: a twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997, 40:441-445. A thorough epidemiologic study that spans almost three decades and is based on hospital records and documented cases.
4. Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI, LeRoy EC, McGregor AR, Diat F, Rosal EJ: Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989, 32:998-1002.
5. Mayes MD, Laing TJ, Gillespie BW, Cooper BC, Lacey JV Jr, Hirschenberger WS, Atty SM, Schottenfeld D: Prevalence, incidence and survival rates of systemic sclerosis in the Detroit metropolitan area [abstract]. Arthritis Rheum 1996, 39:S150.
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-588.
7. Silman A, Jannini S, Symmons D, Bacon P: An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988, 27:286-290.
8. Tamaki T, Mon S, Takehara K: Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991, 283:366-370.
9. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V: Systemic sclerosis in Iceland: a nationwide epidemiological study. Ann Rheum Dis 1994, 53:502-505.
10. Chandran G, Smith M, Ahern MJ, Roberts-Thomson PJ: A study of scleroderma in south Australia: prevalence, subset characteristics and nail-fold capillaroscopy. Aust N Z J Med 1995, 25:688-694.
11. Silman AJ, Howard Y, Hicklin AJ, Black C: Geographical clustering of scleroderma in south and west London. Br J Rheumatol 1990, 29:92-96.
12. Valesini G, Litta A, Bonavita MS, Luan FL, Purpura M, Mariani M, Balsano F: Geographical clustering of scleroderma In a rural area in the province of Rome. Clin Exp Rheumatol 1993, 11:41-47.
13. Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD: Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma: association with an Amerindian HLA haplotype. Arthritis Rheum 1996, 39:1362-1370. This paper reports the highest incidence rate to date of a subset of scleroderma cases. Although the candidate genes may not be applicable to all scleroderma populations, this is an exciting finding and may open the door to the identification of other relevant genes.
14. Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH Jr, Burns CJ, Johanns JR, Cooper BC, Keroack BJ, Wasko MCM, et al.: Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997, 40:734-742. An excellent description of different epidemiologic, clinical, and serologic features of these two populations.
15. Manolios N, Dunckley H, Chivers T, Brooks P, Englert H: Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants. J Rheumatol 1995, 22:85-92.
16. McColl GJ, Buchanan RR: Familial CREST syndrome. J Rheumatol 1994, 21:754-757.
17. McGregor AR, Watson A, Yunis E, Pandey JP, Takehara K, Tidwell JT, Ruggieri A, Silver RM, LeRoy EC, Maricq HR: Familial clustering of scleroderma spectrum disease. Am J Med 1988, 84:1023-1027.
18. McHugh NJ, Whyte J, Artlett C, Briggs DC, Stephens CO, Olsen NJ, Gusseva NG, Maddison PJ, Black CM, Welsh K: Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin Exp Immunol 1994, 96:267-274.
19. Soppi E, Lehtonen A, Toivanen A: Familial progressive systemic sclerosis (scleroderma): Immunological analysis of two patients and six siblings from a single kindred. Clin Exp Immunol 1982, 50:275-279.
20. Mayes MD: Scleroderma epidemiology. Rheum Dis Clin North Am 1996, 22:751-764.
21. Feghali CA, Wright TM: Epidemiologic and clinical study of twins with scleroderma [abstract]. Arthritis Rheum 1995, 38:S308.
22. Harvey G, Black C, Maddison P, McHugh N: Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. J Rheumatol 1997, 24:477-484.
23. Christy WC, Rodnan GP: Conjugal progressive systemic sclerosis (scleroderma): report of the disease in husband and wife. Arthritis Rheum 1984, 27:1180-1184.
24. Bulpitt KJ, Clements PJ, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS, Singer JZ, Steen VD, Clegg DO, Ziminski CM, et al.: Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 1993, 118:602-609.
25. Farmer RG, Gifford RW, Hines EA: Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. Circulation 1960, 21:1088-1092.
26. Medsger TA, Rodnan GP, Robinson H: Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors In 309 patients. Ann Intern Med 1971, 75:369-374.
27. Nietert P, Sutherland S, Silver R, Pandey J, Dosemeci M: Occupational solvent exposure: a risk factor for systemic sclerosis [abstract]? Arthritis Rheum 1996, 39:S318.
28. Goldman JA: Connective tissue disease in people exposed to organic chemical solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workers [abstract]. Arthritis Rheum 1996, 39:S150.
29. Laing T, Gillespie B, Burns C, Garabrant D, Heeringa S, Alcser K, Schottenfeld D, Mayes MD: Risk factors for scleroderma among Michigan women [abstract]. Arthritis Rheum 1995, 38:S341.
30. Peterson LS, Nelson AM, Su WPD, Mason B, O'Fallon WM, Gabriel SE: The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997, 24:73-80.
31. Maricq HR, Weinrich MC, Keil JE, LeRoy EC: Prevalence of Raynaud phenomenon in the general population. J Chronic Dis 1986, 39:423-427.
32. Weinrich MC, Maricq HR, Keil JE, McGregor AR, Diat F: Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 1990, 43:1343-1349.
33. Freedman RR, Mayes MD: Familial aggregation of primary Raynaud's disease. Arthritis Rheum 1996, 39:1189-1191.